Filter by Categories

Something for Your Espresso: China move confirmed!

The crossroads for the Chinese economy we highlighted earlier in the week has been decided (at least intermediately) with the recent JUMP in Li Keqiang. Our early conviction in pro-cyclical trends keeps getting confirmed.
2024-03-22

Our early conviction in pro-cyclical trends keeps getting confirmed. Initially, our nowcast indicator for China signaled a positive outlook, and most notably this week, the Li Keqiang Index has experienced its strongest monthly surge since 2005.

South Korea is trading firmly in an uptrend btw, which has been our main bet in equity space since early March

It seems like South Korea is the true catch up trade (outside of Materials in US equity markets) to a reflation story out of China.

We identified China’s crossroads in this week’s EM editorial. Seems right-tail > left-tail currently. 

Chart 1: China revitalization confirmed

The crossroads for the Chinese economy we highlighted earlier in the week has been decided (at least intermediately) with the recent JUMP in Li Keqiang. Our early conviction in pro-cyclical trends keeps getting confirmed.

0 Comments

STENO RESEARCH IS JOINING REAL VISION

From July 2025, Steno Research is joining Real Vision to create the ultimate macro research product for you!

As a subscriber, this means the following:

Yearly subscriber: For legal reasons, we cannot transfer your pre-paid subscription directly. You need to register with Real Vision and then we’ll transfer your pre-paid subscription quickly afterwards. Simply go to https://www.realvision.com/free and sign up - and then we’ll take care of the rest! We will shut down service of Steno Research on July 31st, so be sure to make the transfer to keep receiving our content.

Already a RV subscriber?
Please check that you are using the same e-mail. If yes, you don't need to do anything. If not, please contact [email protected].

Monthly subscriber: Your current monthly subscription with Steno Research will end during July (31st at the latest). To continue accessing our research (and more), you’ll need to sign up for a Real Vision membership. Check out your options on: https://www.realvision.com/pricing

For Institutional Clients:
- Your access has been moved to our new institutional offering at NowcastIQ.com
- If you haven’t been moved already, please contact [email protected]